Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2010
12/29/2010CA2764060A1 Topical compositions and methods for wound care
12/29/2010CA2763299A1 Method for treating or ameliorating mucocutaneous or ocular toxicities
12/28/2010USRE42014 Pharmaceutical compositions
12/28/2010US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them
12/28/2010US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/28/2010US7858662 Medicament for the treatment of viral skin and tumour diseases
12/28/2010US7858582 external preparation containing recombinant human growth hormone or recombinant human granulocyte macrophage colony-stimulating factor and pharmaceutical acceptable carrier; corneal lesions and corneal ulcers
12/28/2010US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2
12/28/2010US7858368 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars
12/28/2010US7858105 reducing pigmentation of skin for cosmetic effects by administering tyrosine hydroxylase inhibitors to prevent the biosynthesis of DOPA and catecholamines; thioacetanilide; hyperpigmentation-related medical conditions such as melasma, age spots, freckles, ochronosis, and lentigo
12/28/2010US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response
12/23/2010WO2010147922A1 Deuterated i soindoline- i, 3-dione derivatives as pde4 and tnf-alpha inhibitors
12/23/2010WO2010147742A2 Use of nitrite salts in treating tissue damage
12/23/2010WO2010147440A2 Health food or pharmaceutical composition comprising chestnut shell extract
12/23/2010WO2010147238A1 Agent for preventing or treating abnormality in skin water permeation function
12/23/2010WO2010147133A1 Novel imidazopyridine compound
12/23/2010WO2010147109A1 Angiogenesis inducer comprising genetically modified gelatin and basic fibroblast growth factor
12/23/2010WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor
12/23/2010WO2010146294A1 Plant extract for preparing a composition for controlling melanogenesis, resulting control composition, and control method implementing such a composition
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
12/23/2010WO2010146105A1 S1p1 agonists comprising a bicyclic n-containing ring
12/23/2010WO2010145903A1 New therapeutical uses of inecalcitol
12/23/2010WO2010145655A1 Herbal extract composition comprising petroselinum and ocimum extract
12/23/2010WO2010144959A1 Analogues of anti-fibrotic agents
12/23/2010WO2010104281A3 Composition for improving atopic skin diseases
12/23/2010WO2010100651A4 Compositions of polymeric myrcene
12/23/2010US20100324274 Novel synthetic ganglioside derivatives and compositions thereof
12/23/2010US20100324148 Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
12/23/2010US20100324146 Dendrimeric Enzyme Inhibitors
12/23/2010US20100324145 Crystalline ACAT Inhibitor
12/23/2010US20100324135 Disinfectant and method of making
12/23/2010US20100324132 Methods and compositions for promoting wound healing
12/23/2010US20100324109 Composition for Topical Use
12/23/2010US20100324108 Substituted isoindoline-1,3-dione derivatives
12/23/2010US20100324105 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324089 Anti-inflammatory composition
12/23/2010US20100324082 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
12/23/2010US20100324070 Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists
12/23/2010US20100324007 Oral suspension of prednisolone acetate
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323998 Topical composition containing the combination of mupirocin and beclomethasone
12/23/2010US20100323994 Substituted imidazopyridazines useful as kinase inhibitors
12/23/2010US20100323991 Methods and products for treatment of diseases
12/23/2010US20100323985 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
12/23/2010US20100323984 Cosmetic oral and/or parenteral use of glucosamine optionally in combination with at least one polyphenol compound, and corresponding composition
12/23/2010US20100323983 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof, and uses thereof
12/23/2010US20100323980 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
12/23/2010US20100323962 Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing by Applying Peptides Related to Basic Fibroblast Growth Factor (bFGF)
12/23/2010US20100323961 Surface eroding sutures
12/23/2010US20100323029 Five-coordinate neuroglobin and use thereof as a blood substitute
12/23/2010US20100323027 Mesenchymal stem cell conditioned medium
12/23/2010US20100322998 Skin ulcer preventive curative agent containing human recombinant hgf
12/23/2010US20100322997 Method for producing biologically ingestible microparticles, biologically ingestible microparticles, and dispersion and pharmaceutical composition containing the same
12/23/2010US20100322989 Hydrophilic skin cleaning cloth
12/23/2010US20100322982 Alloplastic injectable dermal filler and methods of use thereof
12/23/2010US20100322973 Anti-allergic agent
12/23/2010US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same
12/23/2010US20100322920 Human monoclonal antibodies against CD30
12/23/2010US20100322878 Personal Care Composition Comprising a Synthetic Cationic Polymer
12/23/2010US20100322875 Silicone scar treatment preparation
12/23/2010US20100322863 Methods and Uses of Anti-IL-23 Antibodies
12/23/2010US20100322856 Compositions and Methods for Inducing Angiogenesis
12/23/2010DE202010014503U1 Wässrige Lösung zum Spülen von Geweben oder Organen Aqueous solution for rinsing of tissues or organs
12/23/2010CA2765015A1 Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors
12/23/2010CA2762458A1 New therapeutical uses of inecalcitol
12/22/2010EP2264171A1 Anti-myosine Va siRNA and skin depigmentation
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263683A1 Agent for treating skin aging and scars
12/22/2010EP2263677A1 New therapeutical uses of inecalcitol
12/22/2010EP2263650A2 Nanoparticulate megestrol formulations
12/22/2010EP2263481A1 Green tea extracts of improved bioavailability
12/22/2010EP2262516A2 Composition containing capsicum for treating a skin disorder
12/22/2010EP2262507A1 Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin d compound
12/22/2010EP2262503A1 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
12/22/2010EP2262474A2 Methods and compositions for wound healing
12/22/2010EP2262471A2 Composition and uses for influencing hair growth
12/22/2010EP2178873B1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
12/22/2010EP1871353B1 Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
12/22/2010EP1596879B1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
12/22/2010EP1412317B1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities
12/22/2010EP1214064B1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
12/22/2010EP1135496B1 Ucp5
12/22/2010CN201676082U Burning-caused inflammation eliminating swab for medical use
12/22/2010CN1990045B Highly effective plaster for burn and scald and its preparation process
12/22/2010CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/22/2010CN1547477B Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
12/22/2010CN101925584A Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, HIV, HPV, bacterial infections and dermatosis
12/22/2010CN101925383A Carboxamide compounds and their use as chemokine receptor agonists
12/22/2010CN101925359A Composition
12/22/2010CN101925353A VEGFC production promoter
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921279A Spirocyclic heterocyclic derivatives and methods of their use
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921266A 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof
12/22/2010CN101920005A Novel skin radiation injury protective agent
12/22/2010CN101919997A Prescription for treating neurodermatitis
12/22/2010CN101919993A Medicament for treating psoriasis
1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 1065